Pulmonary nodules seen by computed tomography (CT) can be benign or malignant, and early detection is important for optimal management. The existing manual methods of identifying nodules have limitations, such as being time-consuming and erroneous. This study aims to develop an Artificial Intelligence (AI) diagnostic scheme that improves the performance of identifying and categorizing pulmonary nodules using CT scans. The proposed deep learning framework used convolutional neural networks, and the image database totaled 1,056 3D-DICOM CT images. The framework was initially preprocessing, including lung segmentation, nodule detection, and classification. Nodule detection was done using the Retina-UNet model, while the features were classified using a Support Vector Machine (SVM). Performance measures, including accreditation, sensitivity, specificity, and the AUROC, were used to evaluate the model's performance during training and validation. Overall, the developed AI model received an AUROC of 0.9058. The diagnostic accuracy was 90.58%, with an overall positive predictive value of 89% and an overall negative predictive value of 86%. The algorithm effectively handled the CT images at the preprocessing stage, and the deep learning model performed well in detecting and classifying nodules. The application of the new diagnostic framework based on AI algorithms increased the accuracy of the diagnosis compared with the traditional approach. It also provides high reliability for detecting pulmonary nodules and classifying the lesions, thus minimizing intra-observer differences and improving the clinical outcome. In perspective, the advancements may include increasing the size of the annotated data-set and fine-tuning the model due to detection issues of non-solitary nodules.

Accurate and comprehensive interpretation of pulmonary embolism (PE) from Computed Tomography Pulmonary Angiography (CTPA) scans remains a clinical challenge due to the limited specificity and structure of existing AI tools. We propose an agent-based framework that integrates Vision-Language Models (VLMs) for detecting 32 PE-related abnormalities and Large Language Models (LLMs) for structured report generation. Trained on over 69,000 CTPA studies from 24,890 patients across Brown University Health (BUH), Johns Hopkins University (JHU), and the INSPECT dataset from Stanford, the model demonstrates strong performance in abnormality classification and report generation. For abnormality classification, it achieved AUROC scores of 0.788 (BUH), 0.754 (INSPECT), and 0.710 (JHU), with corresponding BERT-F1 scores of 0.891, 0.829, and 0.842. The abnormality-guided reporting strategy consistently outperformed the organ-based and holistic captioning baselines. For survival prediction, a multimodal fusion model that incorporates imaging, clinical variables, diagnostic outputs, and generated reports achieved concordance indices of 0.863 (BUH) and 0.731 (JHU), outperforming traditional PESI scores. This framework provides a clinically meaningful and interpretable solution for end-to-end PE diagnosis, structured reporting, and outcome prediction.

Introduction: Chest CT scans are increasingly used in dyspneic patients where acute heart failure (AHF) is a key differential diagnosis. Interpretation remains challenging and radiology reports are frequently delayed due to a radiologist shortage, although flagging such information for emergency physicians would have therapeutic implication. Artificial intelligence (AI) can be a complementary tool to enhance the diagnostic precision. We aim to develop an explainable AI model to detect radiological signs of AHF in chest CT with an accuracy comparable to thoracic radiologists. Methods: A single-center, retrospective study during 2016-2021 at Copenhagen University Hospital - Bispebjerg and Frederiksberg, Denmark. A Boosted Trees model was trained to predict AHF based on measurements of segmented cardiac and pulmonary structures from acute thoracic CT scans. Diagnostic labels for training and testing were extracted from radiology reports. Structures were segmented with TotalSegmentator. Shapley Additive explanations values were used to explain the impact of each measurement on the final prediction. Results: Of the 4,672 subjects, 49% were female. The final model incorporated twelve key features of AHF and achieved an area under the ROC of 0.87 on the independent test set. Expert radiologist review of model misclassifications found that 24 out of 64 (38%) false positives and 24 out of 61 (39%) false negatives were actually correct model predictions, with the errors originating from inaccuracies in the initial radiology reports. Conclusion: We developed an explainable AI model with strong discriminatory performance, comparable to thoracic radiologists. The AI model's stepwise, transparent predictions may support decision-making.

Accurate classification of pulmonary pure ground-glass nodules (pGGNs) is essential for distinguishing invasive adenocarcinoma (IVA) from adenocarcinoma in situ (AIS) and minimally invasive adenocarcinoma (MIA), which significantly influences treatment decisions. This study aims to develop a high-precision integrated strategy by combining radiomics-based feature extraction, Quantum Machine Learning (QML) models, and SHapley Additive exPlanations (SHAP) analysis to improve diagnostic accuracy and interpretability in pGGN classification. A total of 322 pGGNs from 275 patients were retrospectively analyzed. The CT images was randomly divided into training and testing cohorts (80:20), with radiomic features extracted from the training cohort. Three QML models-Quantum Support Vector Classifier (QSVC), Pegasos QSVC, and Quantum Neural Network (QNN)-were developed and compared with a classical Support Vector Machine (SVM). SHAP analysis was applied to interpret the contribution of radiomic features to the models' predictions. All three QML models outperformed the classical SVM, with the QNN model achieving the highest improvements ([Formula: see text]) in classification metrics, including accuracy (89.23%, 95% CI: 81.54% - 95.38%), sensitivity (96.55%, 95% CI: 89.66% - 100.00%), specificity (83.33%, 95% CI: 69.44% - 94.44%), and area under the curve (AUC) (0.937, 95% CI: 0.871 - 0.983), respectively. SHAP analysis identified Low Gray Level Run Emphasis (LGLRE), Gray Level Non-uniformity (GLN), and Size Zone Non-uniformity (SZN) as the most critical features influencing classification. This study demonstrates that the proposed integrated strategy, combining radiomics, QML models, and SHAP analysis, significantly enhances the accuracy and interpretability of pGGN classification, particularly in small-sample datasets. It offers a promising tool for early, non-invasive lung cancer diagnosis and helps clinicians make more informed treatment decisions. Not applicable.

Lung cancer remains the leading cause of cancer-related mortality worldwide, largely due to late-stage diagnosis. Early detection is critical for improving patient outcomes, yet current screening methods, such as low-dose computed tomography (CT), often lack the sensitivity and specificity required for early-stage detection. Here, we present a multimodal early screening platform that integrates a multiplexed laser-induced graphene (LIG) immunosensor with machine learning to enhance the accuracy of lung cancer diagnosis. Our platform enables the rapid, cost-effective, and simultaneous detection of four tumor markers─neuron-specific enolase (NSE), carcinoembryonic antigen (CEA), p53, and SOX2─with limits of detection (LOD) as low as 1.62 pg/mL. By combining proteomic data from the immunosensor with deep learning-based CT imaging features and clinical data, we developed a multimodal predictive model that achieves an area under the curve (AUC) of 0.936, significantly outperforming single-modality approaches. This platform offers a transformative solution for early lung cancer screening, particularly in resource-limited settings, and provides potential technical support for precision medicine in oncology.

The rapid and accurate detection of COVID-19 (coronavirus disease 2019) from normal and pneumonia chest x-ray images is essential for timely diagnosis and treatment. The overlapping features in radiology images make it challenging for radiologists to distinguish COVID-19 cases. This research study investigates the effectiveness of combining local binary pattern (LBP) and histogram of oriented gradients (HOG) features with machine learning algorithms to differentiate COVID-19 from normal and pneumonia cases using chest x-rays. The proposed hybrid fusion model "RadientFusion-XR" utilizes LBP and HOG features with shallow learning algorithms. The proposed hybrid HOG-LBP fusion model, RadientFusion-XR, detects COVID-19 cases from normal and pneumonia classes. This fusion model provides a comprehensive representation, enabling more precise differentiation among the three classes. This methodology presents a promising and efficient tool for early COVID-19 and pneumonia diagnosis in clinical settings, with potential integration into automated diagnostic systems. The findings highlight the potential of this hybrid feature extraction and a shallow learning approach to improve diagnostic accuracy in chest x-ray analysis significantly. The hybrid model using LBP and HOG features with an ensemble model achieved an exceptional accuracy of 99% for binary class (COVID-19, normal) and 97% for multi-class (COVID-19, normal, pneumonia), respectively. These results demonstrate the efficacy of our hybrid approach in enhancing feature representation and achieving superior classification accuracy. The proposed RadientFusion-XR model with hybrid feature extraction and shallow learning approach significantly increases the accuracy of COVID-19 and pneumonia diagnoses from chest x-rays. The interpretable nature of RadientFusion-XR, alongside its effectiveness and explainability, makes it a valuable tool for clinical applications, fostering trust and enabling informed decision-making by healthcare professionals.

Pneumonia detection in chest X-rays (CXR) increasingly relies on AI-driven diagnostic systems. However, their "black-box" nature often lacks transparency, underscoring the need for interpretability to improve patient outcomes. This study presents the first application of the Deformable Prototypical Part Network (D-ProtoPNet), an ante-hoc interpretable deep learning (DL) model, for pneumonia classification in pediatric patients' CXR images. Clinical insights were integrated through expert radiologist evaluation of the model's learned prototypes and activated image patches, ensuring that explanations aligned with medically meaningful features. The model was developed and tested on a retrospective dataset of 5,856 CXR images of pediatric patients, ages 1-5 years. The images were originally acquired at a tertiary academic medical center as part of routine clinical care and were publicly hosted on a Kaggle platform. This dataset comprised anterior-posterior images labeled normal, viral, and bacterial. It was divided into 80 % training and 20 % validation splits, and utilised in a supervised five-fold cross-validation. Performance metrics were compared with the original ProtoPNet, utilising ResNet50 as the base model. An experienced radiologist assessed the clinical relevance of the learned prototypes, patch activations, and model explanations. The D-ProtoPNet achieved an accuracy of 86 %, precision of 86 %, recall of 85 %, and AUC of 93 %, marking a 3 % improvement over the original ProtoPNet. While further optimisation is required before clinical use, the radiologist praised D-ProtoPNet's intuitive explanations, highlighting its interpretability and potential to aid clinical decision-making. Prototypical part learning offers a balance between classification performance and explanation quality, but requires improvements to match the accuracy of black-box models. This study underscores the importance of integrating domain expertise during model evaluation to ensure the interpretability of XAI models is grounded in clinically valid insights.

Recent works have revisited the infamous task ``Name That Dataset'', demonstrating that non-medical datasets contain underlying biases and that the dataset origin task can be solved with high accuracy. In this work, we revisit the same task applied to popular open-source chest X-ray datasets. Medical images are naturally more difficult to release for open-source due to their sensitive nature, which has led to certain open-source datasets being extremely popular for research purposes. By performing the same task, we wish to explore whether dataset bias also exists in these datasets. To extend our work, we apply simple transformations to the datasets, repeat the same task, and perform an analysis to identify and explain any detected biases. Given the importance of AI applications in medical imaging, it's vital to establish whether modern methods are taking shortcuts or are focused on the relevant pathology. We implement a range of different network architectures on the datasets: NIH, CheXpert, MIMIC-CXR and PadChest. We hope this work will encourage more explainable research being performed in medical imaging and the creation of more open-source datasets in the medical domain. Our code can be found here: https://github.com/eedack01/x_ray_ds_bias.

<b>BACKGROUND</b>. Artificial intelligence (AI) tools for evaluating low-dose CT (LDCT) lung cancer screening examinations are used predominantly for assisting radiologists' interpretations. Alternate utilization scenarios (e.g., use of AI as a prescreener or backup) warrant consideration. <b>OBJECTIVE</b>. The purpose of this study was to evaluate the impact of different AI utilization scenarios on diagnostic outcomes and interpretation times for LDCT lung cancer screening. <b>METHODS</b>. This retrospective study included 366 individuals (358 men, 8 women; mean age, 64 years) who underwent LDCT from May 2017 to December 2017 as part of an earlier prospective lung cancer screening trial. Examinations were interpreted by one of five readers, who reviewed their assigned cases in two sessions (with and without a commercial AI computer-aided detection tool). These interpretations were used to reconstruct simulated AI utilization scenarios: as an assistant (i.e., radiologists interpret all examinations with AI assistance), as a prescreener (i.e., radiologists only interpret examinations with a positive AI result), or as backup (i.e., radiologists reinterpret examinations when AI suggests a missed finding). A group of thoracic radiologists determined the reference standard. Diagnostic outcomes and mean interpretation times were assessed. Decision-curve analysis was performed. <b>RESULTS</b>. Compared with interpretation without AI (recall rate, 22.1%; per-nodule sensitivity, 64.2%; per-examination specificity, 88.8%; mean interpretation time, 164 seconds), AI as an assistant showed higher recall rate (30.3%; <i>p</i> < .001), lower per-examination specificity (81.1%), and no significant change in per-nodule sensitivity (64.8%; <i>p</i> = .86) or mean interpretation time (161 seconds; <i>p</i> = .48); AI as a prescreener showed lower recall rate (20.8%; <i>p</i> = .02) and mean interpretation time (143 seconds; <i>p</i> = .001), higher per-examination specificity (90.3%; <i>p</i> = .04), and no significant difference in per-nodule sensitivity (62.9%; <i>p</i> = .16); and AI as a backup showed increased recall rate (33.6%; <i>p</i> < .001), per-examination sensitivity (66.4%; <i>p</i> < .001), and mean interpretation time (225 seconds; <i>p</i> = .001), with lower per-examination specificity (79.9%; <i>p</i> < .001). Among scenarios, only AI as a prescreener demonstrated higher net benefit than interpretation without AI; AI as an assistant had the least net benefit. <b>CONCLUSION</b>. Different AI implementation approaches yield varying outcomes. The findings support use of AI as a prescreener as the preferred scenario. <b>CLINICAL IMPACT</b>. An approach whereby radiologists only interpret LDCT examinations with a positive AI result can reduce radiologists' workload while preserving sensitivity.

The labor-intensive nature of medical data annotation presents a significant challenge for respiratory disease diagnosis, resulting in a scarcity of high-quality labeled datasets in resource-constrained settings. Moreover, patient privacy concerns complicate the direct sharing of local medical data across institutions, and existing centralized data-driven approaches, which rely on amounts of available data, often compromise data privacy. This study proposes a federated few-shot learning framework with privacy-preserving mechanisms to address the issues of limited labeled data and privacy protection in diagnosing respiratory diseases. In particular, a meta-stochastic gradient descent algorithm is proposed to mitigate the overfitting problem that arises from insufficient data when employing traditional gradient descent methods for neural network training. Furthermore, to ensure data privacy against gradient leakage, differential privacy noise from a standard Gaussian distribution is integrated into the gradients during the training of private models with local data, thereby preventing the reconstruction of medical images. Given the impracticality of centralizing respiratory disease data dispersed across various medical institutions, a weighted average algorithm is employed to aggregate local diagnostic models from different clients, enhancing the adaptability of a model across diverse scenarios. Experimental results show that the proposed method yields compelling results with the implementation of differential privacy, while effectively diagnosing respiratory diseases using data from different structures, categories, and distributions.